Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer

Introduction We report a patient with the complete remission of multiple metastases and primary bladder lesions of bladder cancer who developed primary lung cancer requiring radical resection. Case presentation A 68‐year‐old man diagnosed with invasive bladder cancer, right hydroureteronephrosis, an...

Full description

Bibliographic Details
Main Authors: Ryohta Nakamura, Go Hasegawa, Kazumasa Ohashi, Takehisa Hashimoto, Yohei Ikeda, Noboru Hara, Tsutomu Nishiyama
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:IJU Case Reports
Subjects:
Online Access:https://doi.org/10.1002/iju5.12550
_version_ 1797966567085965312
author Ryohta Nakamura
Go Hasegawa
Kazumasa Ohashi
Takehisa Hashimoto
Yohei Ikeda
Noboru Hara
Tsutomu Nishiyama
author_facet Ryohta Nakamura
Go Hasegawa
Kazumasa Ohashi
Takehisa Hashimoto
Yohei Ikeda
Noboru Hara
Tsutomu Nishiyama
author_sort Ryohta Nakamura
collection DOAJ
description Introduction We report a patient with the complete remission of multiple metastases and primary bladder lesions of bladder cancer who developed primary lung cancer requiring radical resection. Case presentation A 68‐year‐old man diagnosed with invasive bladder cancer, right hydroureteronephrosis, and multiple metastases were administered six courses of gemcitabine and carboplatin chemotherapy and thereafter has been receiving pembrolizumab therapy. Bladder cancer and multiple metastases decreased in size, whereas a ground‐glass opacity lesion in the lung gradually increased in size. Fluorodeoxyglucose‐positron emission tomography revealed the accumulation of fluorodeoxyglucose in the ground‐glass opacity lesion only. The patient was diagnosed with primary lung cancer and underwent a thoracoscopic lobectomy. Histopathological findings showed ALK‐negative, EGFR L858R mutation‐positive invasive adenocarcinoma with a programmed death‐ligand 1 tumor proportion score of less than 1%. Conclusion This is the first case report of patients with the complete remission of multiple metastases of bladder cancer who developed primary lung cancer requiring radical resection.
first_indexed 2024-04-11T02:17:27Z
format Article
id doaj.art-ab56b1ae05604d328039f277cce51d83
institution Directory Open Access Journal
issn 2577-171X
language English
last_indexed 2024-04-11T02:17:27Z
publishDate 2023-01-01
publisher Wiley
record_format Article
series IJU Case Reports
spelling doaj.art-ab56b1ae05604d328039f277cce51d832023-01-03T00:53:57ZengWileyIJU Case Reports2577-171X2023-01-0161858810.1002/iju5.12550Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancerRyohta Nakamura0Go Hasegawa1Kazumasa Ohashi2Takehisa Hashimoto3Yohei Ikeda4Noboru Hara5Tsutomu Nishiyama6Department of Urology, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata JapanDepartment of Pathology, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata JapanDepartment of Respiratory Medicine, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata JapanDepartment of Respiratory Surgery, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata JapanDepartment of Diagnostic Radiology, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata JapanDepartment of Urology, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata JapanDepartment of Urology, Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Minamiuonuma Niigata JapanIntroduction We report a patient with the complete remission of multiple metastases and primary bladder lesions of bladder cancer who developed primary lung cancer requiring radical resection. Case presentation A 68‐year‐old man diagnosed with invasive bladder cancer, right hydroureteronephrosis, and multiple metastases were administered six courses of gemcitabine and carboplatin chemotherapy and thereafter has been receiving pembrolizumab therapy. Bladder cancer and multiple metastases decreased in size, whereas a ground‐glass opacity lesion in the lung gradually increased in size. Fluorodeoxyglucose‐positron emission tomography revealed the accumulation of fluorodeoxyglucose in the ground‐glass opacity lesion only. The patient was diagnosed with primary lung cancer and underwent a thoracoscopic lobectomy. Histopathological findings showed ALK‐negative, EGFR L858R mutation‐positive invasive adenocarcinoma with a programmed death‐ligand 1 tumor proportion score of less than 1%. Conclusion This is the first case report of patients with the complete remission of multiple metastases of bladder cancer who developed primary lung cancer requiring radical resection.https://doi.org/10.1002/iju5.12550advanced bladder cancerpembrolizumab therapy following gemcitabine and carboplatin chemotherapy with complete remissionprimary lung cancer with radical resection
spellingShingle Ryohta Nakamura
Go Hasegawa
Kazumasa Ohashi
Takehisa Hashimoto
Yohei Ikeda
Noboru Hara
Tsutomu Nishiyama
Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer
IJU Case Reports
advanced bladder cancer
pembrolizumab therapy following gemcitabine and carboplatin chemotherapy with complete remission
primary lung cancer with radical resection
title Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer
title_full Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer
title_fullStr Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer
title_full_unstemmed Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer
title_short Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer
title_sort primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer
topic advanced bladder cancer
pembrolizumab therapy following gemcitabine and carboplatin chemotherapy with complete remission
primary lung cancer with radical resection
url https://doi.org/10.1002/iju5.12550
work_keys_str_mv AT ryohtanakamura primarylungcancertreatablewithradicalresectionaftercompleteremissionwithpembrolizumabtherapyfollowinggemcitabineandcarboplatinchemotherapyformultiplemetastasesofbladdercancer
AT gohasegawa primarylungcancertreatablewithradicalresectionaftercompleteremissionwithpembrolizumabtherapyfollowinggemcitabineandcarboplatinchemotherapyformultiplemetastasesofbladdercancer
AT kazumasaohashi primarylungcancertreatablewithradicalresectionaftercompleteremissionwithpembrolizumabtherapyfollowinggemcitabineandcarboplatinchemotherapyformultiplemetastasesofbladdercancer
AT takehisahashimoto primarylungcancertreatablewithradicalresectionaftercompleteremissionwithpembrolizumabtherapyfollowinggemcitabineandcarboplatinchemotherapyformultiplemetastasesofbladdercancer
AT yoheiikeda primarylungcancertreatablewithradicalresectionaftercompleteremissionwithpembrolizumabtherapyfollowinggemcitabineandcarboplatinchemotherapyformultiplemetastasesofbladdercancer
AT noboruhara primarylungcancertreatablewithradicalresectionaftercompleteremissionwithpembrolizumabtherapyfollowinggemcitabineandcarboplatinchemotherapyformultiplemetastasesofbladdercancer
AT tsutomunishiyama primarylungcancertreatablewithradicalresectionaftercompleteremissionwithpembrolizumabtherapyfollowinggemcitabineandcarboplatinchemotherapyformultiplemetastasesofbladdercancer